Halozyme Therapeutics, Inc. (LON:0J2O)
London · Delayed Price · Currency is GBP · Price in USD 56.72
-0.99 (-1.71%)
At close: Jul 15, 2025
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of 5.17 billion as of July 18, 2025. Its market cap has increased by 0.46% in one year.
Market Cap
5.17B
Enterprise Value
5.76B
Revenue
839.24M
Ranking
n/a
PE Ratio
13.77
Stock Price
56.72
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 95.57M to 5.17B, an increase of 5,313.44%. That is a compound annual growth rate of 20.73%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.83B |
| GSK plc | 57.49B |
| Haleon | 32.34B |
| Smith & Nephew | 9.59B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.35B |
| HUTCHMED (China) | 2.14B |
| Genus | 1.57B |